Subcutaneous adipose tissue sclerostin is reduced and Wnt signaling is enhanced following 4‐weeks of sprint interval training in young men with obesity

Sclerostin is a Wnt/β‐catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone–adipose tissue crosstalk. Exercise training has been shown to...

Full description

Saved in:
Bibliographic Details
Published in:Physiological reports Vol. 10; no. 6; pp. e15232 - n/a
Main Authors: Kurgan, Nigel, Islam, Hashim, Matusiak, Jennifer B. L., Baranowski, Bradley J., Stoikos, Joshua, Fajardo, Val A., MacPherson, Rebecca E. K., Gurd, Brendon J., Klentrou, Panagiota
Format: Journal Article
Language:English
Published: United States John Wiley & Sons, Inc 01-03-2022
John Wiley and Sons Inc
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Sclerostin is a Wnt/β‐catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone–adipose tissue crosstalk. Exercise training has been shown to reduce plasma sclerostin levels; but the effects of exercise on sclerostin and Wnt/β‐catenin signaling specifically within adipose tissue has yet to be examined. The purpose of this study was to examine subcutaneous WAT (scWAT) sclerostin content and Wnt signaling in response to exercise training in young men with obesity. To this end, 7 male participants (BMI = 35 ± 4; 25 ± 4 years) underwent 4 weeks of sprint interval training (SIT) involving 4 weekly sessions consisting of a 5‐min warmup, followed by 8 × 20 s intervals at 170% of work rate at VO2peak, separated by 10 s of rest. Serum and scWAT were sampled at rest both pre‐ and post‐SIT. Despite no changes in serum sclerostin levels, we found a significant decrease in adipose sclerostin content (−37%, p = 0.04), an increase in total β‐catenin (+52%, p = 0.03), and no changes in GSK3β serine 9 phosphorylation. There were also concomitant reductions in serum TNF‐α (−0.36 pg/ml, p = 0.03) and IL‐6 (−1.44 pg/ml, p = 0.05) as well as an increase in VO2peak (+5%, p = 0.03) and scWAT COXIV protein content (+95%, p = 0.04). In conclusion, scWAT sclerostin content was reduced and β‐catenin content was increased following SIT in young men with excess adiposity, suggesting a role of sclerostin in regulating human adipose tissue in response to exercise training. In this study, we examined sclerostin content in serum and subcutaneous adipose tissue both pre‐ and post‐exercise training in humans with obesity. Our data support that sclerostin decreases while Wnt/β signaling, the pathway sclerostin antagonizes, increases in adipose tissue fol. These results provide observational evidence for an endocrine role of sclerostin in humans and suggest a role of sclerostin/Wnt signaling in exercise induced adipose tissue adaptations.
AbstractList Abstract Sclerostin is a Wnt/β‐catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone–adipose tissue crosstalk. Exercise training has been shown to reduce plasma sclerostin levels; but the effects of exercise on sclerostin and Wnt/β‐catenin signaling specifically within adipose tissue has yet to be examined. The purpose of this study was to examine subcutaneous WAT (scWAT) sclerostin content and Wnt signaling in response to exercise training in young men with obesity. To this end, 7 male participants (BMI = 35 ± 4; 25 ± 4 years) underwent 4 weeks of sprint interval training (SIT) involving 4 weekly sessions consisting of a 5‐min warmup, followed by 8 × 20 s intervals at 170% of work rate at VO2peak, separated by 10 s of rest. Serum and scWAT were sampled at rest both pre‐ and post‐SIT. Despite no changes in serum sclerostin levels, we found a significant decrease in adipose sclerostin content (−37%, p = 0.04), an increase in total β‐catenin (+52%, p = 0.03), and no changes in GSK3β serine 9 phosphorylation. There were also concomitant reductions in serum TNF‐α (−0.36 pg/ml, p = 0.03) and IL‐6 (−1.44 pg/ml, p = 0.05) as well as an increase in VO2peak (+5%, p = 0.03) and scWAT COXIV protein content (+95%, p = 0.04). In conclusion, scWAT sclerostin content was reduced and β‐catenin content was increased following SIT in young men with excess adiposity, suggesting a role of sclerostin in regulating human adipose tissue in response to exercise training.
Sclerostin is a Wnt/β-catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone-adipose tissue crosstalk. Exercise training has been shown to reduce plasma sclerostin levels; but the effects of exercise on sclerostin and Wnt/β-catenin signaling specifically within adipose tissue has yet to be examined. The purpose of this study was to examine subcutaneous WAT (scWAT) sclerostin content and Wnt signaling in response to exercise training in young men with obesity. To this end, 7 male participants (BMI = 35 ± 4; 25 ± 4 years) underwent 4 weeks of sprint interval training (SIT) involving 4 weekly sessions consisting of a 5-min warmup, followed by 8 × 20 s intervals at 170% of work rate at VO2peak , separated by 10 s of rest. Serum and scWAT were sampled at rest both pre- and post-SIT. Despite no changes in serum sclerostin levels, we found a significant decrease in adipose sclerostin content (-37%, p = 0.04), an increase in total β-catenin (+52%, p = 0.03), and no changes in GSK3β serine 9 phosphorylation. There were also concomitant reductions in serum TNF-α (-0.36 pg/ml, p = 0.03) and IL-6 (-1.44 pg/ml, p = 0.05) as well as an increase in VO2peak (+5%, p = 0.03) and scWAT COXIV protein content (+95%, p = 0.04). In conclusion, scWAT sclerostin content was reduced and β-catenin content was increased following SIT in young men with excess adiposity, suggesting a role of sclerostin in regulating human adipose tissue in response to exercise training.Sclerostin is a Wnt/β-catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone-adipose tissue crosstalk. Exercise training has been shown to reduce plasma sclerostin levels; but the effects of exercise on sclerostin and Wnt/β-catenin signaling specifically within adipose tissue has yet to be examined. The purpose of this study was to examine subcutaneous WAT (scWAT) sclerostin content and Wnt signaling in response to exercise training in young men with obesity. To this end, 7 male participants (BMI = 35 ± 4; 25 ± 4 years) underwent 4 weeks of sprint interval training (SIT) involving 4 weekly sessions consisting of a 5-min warmup, followed by 8 × 20 s intervals at 170% of work rate at VO2peak , separated by 10 s of rest. Serum and scWAT were sampled at rest both pre- and post-SIT. Despite no changes in serum sclerostin levels, we found a significant decrease in adipose sclerostin content (-37%, p = 0.04), an increase in total β-catenin (+52%, p = 0.03), and no changes in GSK3β serine 9 phosphorylation. There were also concomitant reductions in serum TNF-α (-0.36 pg/ml, p = 0.03) and IL-6 (-1.44 pg/ml, p = 0.05) as well as an increase in VO2peak (+5%, p = 0.03) and scWAT COXIV protein content (+95%, p = 0.04). In conclusion, scWAT sclerostin content was reduced and β-catenin content was increased following SIT in young men with excess adiposity, suggesting a role of sclerostin in regulating human adipose tissue in response to exercise training.
Sclerostin is a Wnt/β‐catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone–adipose tissue crosstalk. Exercise training has been shown to reduce plasma sclerostin levels; but the effects of exercise on sclerostin and Wnt/β‐catenin signaling specifically within adipose tissue has yet to be examined. The purpose of this study was to examine subcutaneous WAT (scWAT) sclerostin content and Wnt signaling in response to exercise training in young men with obesity. To this end, 7 male participants (BMI = 35 ± 4; 25 ± 4 years) underwent 4 weeks of sprint interval training (SIT) involving 4 weekly sessions consisting of a 5‐min warmup, followed by 8 × 20 s intervals at 170% of work rate at VO2peak, separated by 10 s of rest. Serum and scWAT were sampled at rest both pre‐ and post‐SIT. Despite no changes in serum sclerostin levels, we found a significant decrease in adipose sclerostin content (−37%, p = 0.04), an increase in total β‐catenin (+52%, p = 0.03), and no changes in GSK3β serine 9 phosphorylation. There were also concomitant reductions in serum TNF‐α (−0.36 pg/ml, p = 0.03) and IL‐6 (−1.44 pg/ml, p = 0.05) as well as an increase in VO2peak (+5%, p = 0.03) and scWAT COXIV protein content (+95%, p = 0.04). In conclusion, scWAT sclerostin content was reduced and β‐catenin content was increased following SIT in young men with excess adiposity, suggesting a role of sclerostin in regulating human adipose tissue in response to exercise training. In this study, we examined sclerostin content in serum and subcutaneous adipose tissue both pre‐ and post‐exercise training in humans with obesity. Our data support that sclerostin decreases while Wnt/β signaling, the pathway sclerostin antagonizes, increases in adipose tissue fol. These results provide observational evidence for an endocrine role of sclerostin in humans and suggest a role of sclerostin/Wnt signaling in exercise induced adipose tissue adaptations.
Sclerostin is a Wnt/β‐catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone–adipose tissue crosstalk. Exercise training has been shown to reduce plasma sclerostin levels; but the effects of exercise on sclerostin and Wnt/β‐catenin signaling specifically within adipose tissue has yet to be examined. The purpose of this study was to examine subcutaneous WAT (scWAT) sclerostin content and Wnt signaling in response to exercise training in young men with obesity. To this end, 7 male participants (BMI = 35 ± 4; 25 ± 4 years) underwent 4 weeks of sprint interval training (SIT) involving 4 weekly sessions consisting of a 5‐min warmup, followed by 8 × 20 s intervals at 170% of work rate at VO 2peak , separated by 10 s of rest. Serum and scWAT were sampled at rest both pre‐ and post‐SIT. Despite no changes in serum sclerostin levels, we found a significant decrease in adipose sclerostin content (−37%, p  = 0.04), an increase in total β‐catenin (+52%, p  = 0.03), and no changes in GSK3β serine 9 phosphorylation. There were also concomitant reductions in serum TNF‐α (−0.36 pg/ml, p  = 0.03) and IL‐6 (−1.44 pg/ml, p  = 0.05) as well as an increase in VO 2peak (+5%, p  = 0.03) and scWAT COXIV protein content (+95%, p  = 0.04). In conclusion, scWAT sclerostin content was reduced and β‐catenin content was increased following SIT in young men with excess adiposity, suggesting a role of sclerostin in regulating human adipose tissue in response to exercise training. In this study, we examined sclerostin content in serum and subcutaneous adipose tissue both pre‐ and post‐exercise training in humans with obesity. Our data support that sclerostin decreases while Wnt/β signaling, the pathway sclerostin antagonizes, increases in adipose tissue fol. These results provide observational evidence for an endocrine role of sclerostin in humans and suggest a role of sclerostin/Wnt signaling in exercise induced adipose tissue adaptations.
Sclerostin is a Wnt/β-catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone-adipose tissue crosstalk. Exercise training has been shown to reduce plasma sclerostin levels; but the effects of exercise on sclerostin and Wnt/β-catenin signaling specifically within adipose tissue has yet to be examined. The purpose of this study was to examine subcutaneous WAT (scWAT) sclerostin content and Wnt signaling in response to exercise training in young men with obesity. To this end, 7 male participants (BMI = 35 ± 4; 25 ± 4 years) underwent 4 weeks of sprint interval training (SIT) involving 4 weekly sessions consisting of a 5-min warmup, followed by 8 × 20 s intervals at 170% of work rate at VO , separated by 10 s of rest. Serum and scWAT were sampled at rest both pre- and post-SIT. Despite no changes in serum sclerostin levels, we found a significant decrease in adipose sclerostin content (-37%, p = 0.04), an increase in total β-catenin (+52%, p = 0.03), and no changes in GSK3β serine 9 phosphorylation. There were also concomitant reductions in serum TNF-α (-0.36 pg/ml, p = 0.03) and IL-6 (-1.44 pg/ml, p = 0.05) as well as an increase in VO (+5%, p = 0.03) and scWAT COXIV protein content (+95%, p = 0.04). In conclusion, scWAT sclerostin content was reduced and β-catenin content was increased following SIT in young men with excess adiposity, suggesting a role of sclerostin in regulating human adipose tissue in response to exercise training.
Sclerostin is a Wnt/β-catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest sclerostin can also regulate adipose tissue mass and metabolism, representing bone–adipose tissue crosstalk. Exercise training has been shown to reduce plasma sclerostin levels; but the effects of exercise on sclerostin and Wnt/β-catenin signaling specifically within adipose tissue has yet to be examined. The purpose of this study was to examine subcutaneous WAT (scWAT) sclerostin content and Wnt signaling in response to exercise training in young men with obesity. To this end, 7 male participants (BMI = 35 ± 4; 25 ± 4 years) underwent 4 weeks of sprint interval training (SIT) involving 4 weekly sessions consisting of a 5-min warmup, followed by 8 × 20 s intervals at 170% of work rate at VO2peak, separated by 10 s of rest. Serum and scWAT were sampled at rest both pre- and post-SIT. Despite no changes in serum sclerostin levels, we found a significant decrease in adipose sclerostin content (−37%, p = 0.04), an increase in total β-catenin (+52%, p = 0.03), and no changes in GSK3β serine 9 phosphorylation. There were also concomitant reductions in serum TNF-α (−0.36 pg/ml, p = 0.03) and IL-6 (−1.44 pg/ml, p = 0.05) as well as an increase in VO2peak (+5%, p = 0.03) and scWAT COXIV protein content (+95%, p = 0.04). In conclusion, scWAT sclerostin content was reduced and β-catenin content was increased following SIT in young men with excess adiposity, suggesting a role of sclerostin in regulating human adipose tissue in response to exercise training.
Author Stoikos, Joshua
Kurgan, Nigel
Gurd, Brendon J.
Baranowski, Bradley J.
Islam, Hashim
Fajardo, Val A.
MacPherson, Rebecca E. K.
Matusiak, Jennifer B. L.
Klentrou, Panagiota
AuthorAffiliation 5 Department of Health Sciences Brock University St. Catharines Ontario Canada
1 Department of Kinesiology Brock University St. Catharines Ontario Canada
3 School of Health and Exercise Sciences University of British Columbia Okanagan Kelowna British Columbia Canada
4 Department of Kinesiology Queens University Kingston Ontario Canada
2 Centre for Bone and Muscle Health Brock University St. Catharines Ontario Canada
AuthorAffiliation_xml – name: 4 Department of Kinesiology Queens University Kingston Ontario Canada
– name: 1 Department of Kinesiology Brock University St. Catharines Ontario Canada
– name: 5 Department of Health Sciences Brock University St. Catharines Ontario Canada
– name: 3 School of Health and Exercise Sciences University of British Columbia Okanagan Kelowna British Columbia Canada
– name: 2 Centre for Bone and Muscle Health Brock University St. Catharines Ontario Canada
Author_xml – sequence: 1
  givenname: Nigel
  orcidid: 0000-0002-5011-0297
  surname: Kurgan
  fullname: Kurgan, Nigel
  organization: Brock University
– sequence: 2
  givenname: Hashim
  surname: Islam
  fullname: Islam, Hashim
  organization: University of British Columbia Okanagan
– sequence: 3
  givenname: Jennifer B. L.
  surname: Matusiak
  fullname: Matusiak, Jennifer B. L.
  organization: Queens University
– sequence: 4
  givenname: Bradley J.
  surname: Baranowski
  fullname: Baranowski, Bradley J.
  organization: Brock University
– sequence: 5
  givenname: Joshua
  surname: Stoikos
  fullname: Stoikos, Joshua
  organization: Brock University
– sequence: 6
  givenname: Val A.
  orcidid: 0000-0003-4500-3347
  surname: Fajardo
  fullname: Fajardo, Val A.
  organization: Brock University
– sequence: 7
  givenname: Rebecca E. K.
  orcidid: 0000-0002-1577-2658
  surname: MacPherson
  fullname: MacPherson, Rebecca E. K.
  organization: Brock University
– sequence: 8
  givenname: Brendon J.
  surname: Gurd
  fullname: Gurd, Brendon J.
  organization: Queens University
– sequence: 9
  givenname: Panagiota
  orcidid: 0000-0003-0328-5198
  surname: Klentrou
  fullname: Klentrou, Panagiota
  email: nklentrou@brocku.ca
  organization: Brock University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35312183$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhi1URNulJ-7IEhcktMWf-bggoQpopUogAQJOlhNPdr1k7cVOusqtP4Erf49fgpOUquXAwbI1886j1zNzjA6cd4DQE0pOqSioeLlbD-yUSsbZA3TEiKTLguZfD-68D9FJjBtCCCWcl0Q8QodccspowY_Qr499VfedduD7iLWxOx8BdzbGHnCsWwg-dtZhG3EA09dgsHYGf3EdjnbldGvdakyCW2s3Zhvftn4_RsXv6597gO8R-wbHXbCpJh0IV7rFXdDWTbUOD75Pjy04vLfdGvsKou2Gx-hho9sIJzf3An1---bT2fny8v27i7PXl8ta5BlbGigyBlRKpmsmGiEL4FIaVomSk7wSBGqqG6IrEHlpspIBEdpUDUt13FQ1X6CLmWu83qhkc6vDoLy2agr4sFI6dDa1QoEgnFV5pRnPRCmFLljRFJw3mhIgJEusVzNr11dbMDW49M_2HvR-xtm1WvkrVZTJNB8Bz28Awf_oIXZqa2MNbTsPSLFMUEmzIhlZoGf_SDe-D2kik0qw1AlZJtWLWVWnQcYAza0ZStS0QWrcIDVtUFI_vev_Vvt3X5KAzYK9bWH4H0t9OP_GZuofdGzWyg
CitedBy_id crossref_primary_10_1177_09636897241236030
crossref_primary_10_1016_j_scispo_2023_03_002
crossref_primary_10_1002_jbmr_4768
crossref_primary_10_1016_j_scispo_2023_03_001
crossref_primary_10_1152_ajplung_00335_2022
crossref_primary_10_3389_fendo_2023_1308408
crossref_primary_10_3390_children10050850
crossref_primary_10_3390_endocrines4020025
crossref_primary_10_1016_j_scispo_2023_11_002
Cites_doi 10.1210/jc.2011‐3361
10.1152/japplphysiol.00496.2018
10.1038/nature10777
10.2147/DMSO.S234992
10.1210/clinem/dgaa571
10.1249/MSS.0000000000000660
10.1016/j.cmet.2013.09.014
10.2337/db06-1339
10.1123/ijsnem.22.4.276
10.1111/sms.13754
10.1242/dev.146589
10.1016/j.celrep.2019.02.014
10.1002/oby.21697
10.2337/dc14‐2989
10.1210/jc.2011‐2152
10.1074/jbc.RA118.006769
10.1002/oby.21669
10.1038/ijo.2013.209
10.3390/proteomes9030038
10.1002/jcp.24487
10.1080/21623945.2018.1489335
10.1111/sms.12252
10.1002/jbmr.3143
10.1016/S0140‐6736(17)31613‐6
10.1152/japplphysiol.00164.2004
10.1111/apha.12247
10.1038/sj.emboj.7600633
10.18632/oncotarget.24707
10.14814/phy2.13857
10.1210/jc.2012‐1218
10.1016/j.bbrc.2014.03.079
10.1002/jbmr.173
10.1016/j.mce.2008.05.005
10.2337/db13‐1234
10.1016/j.exger.2018.07.021
10.1113/jphysiol.2008.165464
10.1016/j.cyto.2013.09.018
10.1159/000497113
10.1007/s11914‐015‐0269‐9
10.1016/S0022‐2275(20)39356‐1
10.1073/pnas.1707876115
10.1042/BCJ20190466
10.1007/s10741‐018‐9677‐0
10.3389/fphys.2018.01781
10.1111/j.1748‐1716.2010.02159.x
10.1016/j.cmet.2018.12.007
10.1016/j.bbi.2019.08.187
10.1096/fj.202100691R
10.1371/journal.pone.0084910
10.1080/21623945.2016.1191307
10.1074/jbc.M402937200
10.1111/sms.13514
10.1016/j.bone.2016.10.011
10.1111/febs.12619
10.1503/cmaj.1040769
10.1016/j.molmet.2016.12.001
10.1038/s41598‐018‐21795‐y
10.1152/japplphysiol.01080.2011
10.1371/journal.pone.0004046
10.1016/j.cmet.2011.06.020
10.4093/dmj.2019.0031
10.1152/ajpendo.00248.2007
10.2337/db14‐1937
10.1016/j.msard.2018.06.008
10.1152/ajpendo.90424.2008
10.1139/apnm‐2017‐0864
10.1371/journal.pone.0071623
10.1002/jbmr.320
10.1074/jbc.M114.628313
10.1359/jbmr.090411
10.1038/ijo.2017.295
10.1371/journal.pone.0102406
10.1016/j.cmet.2012.03.010
10.1016/j.isci.2018.12.033
10.1038/s41467‐020‐19155‐4
10.2337/db13‐1106
10.1002/jcph.239
10.2337/db14‐0704
10.1172/JCI63604
10.1016/j.bone.2018.07.021
ContentType Journal Article
Copyright 2022 The Authors. published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society
2022 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.
2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society
– notice: 2022 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.
– notice: 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QP
7T5
7TK
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.14814/phy2.15232
DatabaseName Wiley-Blackwell Open Access Collection
Wiley Online Library Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate KURGAN et al
EISSN 2051-817X
EndPage n/a
ExternalDocumentID oai_doaj_org_article_e4032b7ba2364954a828f833fa10e006
10_14814_phy2_15232
35312183
PHY215232
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Brock University Library
– fundername: Natural Sciences and Engineering Research Council of Canada
  funderid: 2020‐00014
– fundername: ;
  grantid: 2020‐00014
GroupedDBID 0R~
1OC
24P
53G
5VS
7X7
8-1
8FE
8FH
8FI
8FJ
AAFWJ
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
AEEZP
AEQDE
AFKRA
AFPKN
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
DIK
EBS
EJD
FYUFA
GODZA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IAO
IHR
INH
KQ8
LK8
M48
M7P
M~E
OK1
PIMPY
PQQKQ
PROAC
RAP
RHI
RPM
UKHRP
WIN
CGR
CUY
CVF
ECM
EIF
ITC
NPM
AAYXX
CITATION
3V.
7QP
7T5
7TK
7XB
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c4762-de862e1552ac24f458e355d2b49307b40ec1af0abe479d692e04adbf2e863dbc3
IEDL.DBID RPM
ISSN 2051-817X
IngestDate Tue Oct 22 15:13:14 EDT 2024
Tue Sep 17 21:27:22 EDT 2024
Sat Oct 26 04:14:41 EDT 2024
Mon Nov 18 06:23:15 EST 2024
Thu Sep 26 18:59:27 EDT 2024
Sat Nov 02 11:58:32 EDT 2024
Sat Aug 24 00:56:23 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords bone-adipose tissue crosstalk
Wnt signaling
sprint interval training
sclerostin
Language English
License Attribution
2022 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4762-de862e1552ac24f458e355d2b49307b40ec1af0abe479d692e04adbf2e863dbc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4500-3347
0000-0002-5011-0297
0000-0003-0328-5198
0000-0002-1577-2658
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935536/
PMID 35312183
PQID 2644245859
PQPubID 2034607
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_e4032b7ba2364954a828f833fa10e006
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8935536
proquest_miscellaneous_2641516840
proquest_journals_2644245859
crossref_primary_10_14814_phy2_15232
pubmed_primary_35312183
wiley_primary_10_14814_phy2_15232_PHY215232
PublicationCentury 2000
PublicationDate March 2022
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: March 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Oxford
– name: Hoboken
PublicationTitle Physiological reports
PublicationTitleAlternate Physiol Rep
PublicationYear 2022
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2012; 481
2019; 91
2005; 172
2015; 38
2012; 122
2019; 11
2013; 64
2017; 390
2020; 13
2020; 11
2008; 3
2011; 14
2012; 15
2014; 63
2013; 8
2018; 43
2018; 42
2012; 97
2005; 24
2014; 211
2019; 120
2018; 7
2018; 6
2021; 35
2013; 18
2014; 446
2018; 9
2015; 47
2018; 8
2018; 1985
2015; 290
2007; 293
2017; 32
2019; 26
2019; 29
2011; 26
2017b; 114
2014; 281
2014; 9
1972; 13
2012; 22
2014; 54
2021; 9
2017a; 114
2008; 291
2015; 13
2009; 24
2017; 25
2018; 145
2010; 200
2009; 297
2020; 105
2018; 23
2007; 56
2018; 69
2018; 24
2014; 229
2016; 5
2018; 111
2016; 6
2017; 96
2015; 25
2019; 81
2012; 112
2004; 279
2020; 30
2015; 64
2014; 38
2019
2020; 477
2019; 294
2005; 1985
2009; 587
2016; 24
e_1_2_9_75_1
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_79_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_56_1
e_1_2_9_77_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
e_1_2_9_71_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_58_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_20_1
e_1_2_9_62_1
e_1_2_9_22_1
Janik M. (e_1_2_9_23_1) 2018; 69
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_83_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_81_1
e_1_2_9_4_1
e_1_2_9_60_1
e_1_2_9_2_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_78_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_76_1
e_1_2_9_70_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_61_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_67_1
e_1_2_9_44_1
e_1_2_9_65_1
e_1_2_9_7_1
e_1_2_9_80_1
e_1_2_9_5_1
e_1_2_9_82_1
e_1_2_9_3_1
e_1_2_9_9_1
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
e_1_2_9_69_1
e_1_2_9_29_1
References_xml – volume: 6
  year: 2018
  article-title: High‐intensity interval training changes mitochondrial respiratory capacity differently in adipose tissue and skeletal muscle
  publication-title: Physiological Reports
– volume: 112
  start-page: 1353
  issue: 8
  year: 2012
  end-page: 1360
  article-title: Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high‐intensity intermittent training in overweight and obese males
  publication-title: Journal of Applied Physiology
– volume: 63
  start-page: 2800
  year: 2014
  end-page: 2811
  article-title: Exercise training induces mitochondrial biogenesis and glucose uptake in subcutaneous adipose tissue through eNOS‐dependent mechanisms
  publication-title: Diabetes
– volume: 29
  start-page: 844
  year: 2019
  end-page: 855.e843
  article-title: Exercise‐induced changes in visceral adipose tissue mass are regulated by IL‐6 signaling: A randomized controlled trial
  publication-title: Cell Metabolism
– volume: 8
  year: 2018
  article-title: GSK3 is a negative regulator of the thermogenic program in brown adipocytes
  publication-title: Scientific Reports
– volume: 6
  start-page: 174
  year: 2016
  end-page: 184
  article-title: JNK at the crossroad of obesity, insulin resistance, and cell stress response
  publication-title: Molecular Metabolism
– volume: 294
  start-page: 6899
  year: 2019
  end-page: 6911
  article-title: Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism
  publication-title: Journal of Biological Chemistry
– volume: 281
  start-page: 739
  year: 2014
  end-page: 749
  article-title: The effects of acute and chronic exercise on PGC‐1α, irisin and browning of subcutaneous adipose tissue in humans
  publication-title: FEBS Journal
– volume: 91
  start-page: 1
  year: 2019
  end-page: 8
  article-title: The bone markers sclerostin, osteoprotegerin, and bone‐specific alkaline phosphatase are related to insulin resistance in children and adolescents, independent of their association with growth and obesity
  publication-title: Hormone Research in Paediatrics
– volume: 54
  start-page: 168
  year: 2014
  end-page: 178
  article-title: Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double‐blind, placebo‐controlled study
  publication-title: Journal of Clinical Pharmacology
– volume: 97
  start-page: 148
  year: 2012
  end-page: 154
  article-title: Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults
  publication-title: The Journal of Clinical Endocrinology & Metabolism
– volume: 64
  start-page: 660
  year: 2013
  end-page: 665
  article-title: Reference range and short‐ and long‐term biological variation of interleukin (IL)‐6, IL‐17A and tissue necrosis factor‐alpha using high sensitivity assays
  publication-title: Cytokine
– volume: 63
  start-page: 514
  year: 2014
  end-page: 525
  article-title: Irisin stimulates browning of white adipocytes through mitogen‐activated protein kinase p38 MAP kinase and ERK MAP kinase signaling
  publication-title: Diabetes
– volume: 26
  start-page: 229
  year: 2011
  end-page: 238
  article-title: The amazing osteocyte
  publication-title: Journal of Bone and Mineral Research
– volume: 96
  start-page: 85
  year: 2017
  end-page: 90
  article-title: Serum sclerostin decreases following 12 months of resistance‐or jump‐training in men with low bone mass
  publication-title: Bone
– volume: 23
  start-page: 209
  year: 2018
  end-page: 223
  article-title: Effect of aerobic and resistance training on inflammatory markers in heart failure patients: Systematic review and meta‐analysis
  publication-title: Heart Failure Reviews
– volume: 291
  start-page: 116
  year: 2008
  end-page: 124
  article-title: Roles of Wnt/beta‐catenin signaling in adipogenic differentiation potential of adipose‐derived mesenchymal stem cells
  publication-title: Molecular and Cellular Endocrinology
– volume: 13
  start-page: 193
  year: 2015
  end-page: 197
  article-title: Osteocytes and homeostasis of remote organs: Bone‐buried osteocytes talk to remote organs
  publication-title: Current Osteoporosis Reports
– volume: 43
  start-page: 1059
  year: 2018
  end-page: 1068
  article-title: Contribution of central and peripheral adaptations to changes in maximal oxygen uptake following 4 weeks of sprint interval training
  publication-title: Applied Physiology, Nutrition and Metabolism
– volume: 24
  start-page: 91
  year: 2018
  end-page: 100
  article-title: Effects of exercise training on cytokines and adipokines in multiple Sclerosis: A systematic review
  publication-title: Multiple Sclerosis and Related Disorders
– volume: 9
  year: 2014
  article-title: An examination of resveratrol's mechanisms of action in human tissue: Impact of a single dose in vivo and dose responses in skeletal muscle ex vivo
  publication-title: PLoS One
– volume: 293
  start-page: E726
  year: 2007
  end-page: E736
  article-title: Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats
  publication-title: American Journal of Physiology‐Endocrinology and Metabolism
– volume: 9
  start-page: 18029
  year: 2018
  end-page: 18040
  article-title: Effects of repeated sprints training on fracture risk‐associated miRNA
  publication-title: Oncotarget
– volume: 22
  start-page: 276
  year: 2012
  end-page: 283
  article-title: Two minutes of sprint‐interval exercise elicits 24‐hr oxygen consumption similar to that of 30 min of continuous endurance exercise
  publication-title: International Journal of Sport Nutrition and Exercise Metabolism
– volume: 11
  year: 2020
  article-title: Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
  publication-title: Nature Communications
– volume: 111
  start-page: 188
  year: 2018
  end-page: 196
  article-title: Effect of resistance training on inflammatory markers of older adults: A meta‐analysis
  publication-title: Experimental Gerontology
– volume: 446
  start-page: 1108
  year: 2014
  end-page: 1113
  article-title: New insights into the location and form of sclerostin
  publication-title: Biochemical and Biophysical Research Communications
– volume: 69
  start-page: 142
  year: 2018
  end-page: 149
  article-title: Effects of physical activity on sclerostin concentrations
  publication-title: Endokrynologia Polska
– volume: 11
  start-page: 425
  year: 2019
  end-page: 439
  article-title: Exercise training induces depot‐specific adaptations to white and brown adipose tissue
  publication-title: iScience
– volume: 114
  start-page: E11238
  year: 2017a
  end-page: E11247
  article-title: Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
  publication-title: Proceedings of the National Academy of Sciences
– volume: 120
  start-page: 232
  year: 2019
  end-page: 238
  article-title: Sclerostin and its association with insulin resistance in children and adolescents
  publication-title: Bone
– volume: 279
  start-page: 35503
  year: 2004
  end-page: 35509
  article-title: Wnt10b inhibits development of white and brown adipose tissues
  publication-title: The Journal of Biological Chemistry
– volume: 26
  start-page: 2738
  year: 2019
  end-page: 2752.e2734
  article-title: Exercise alleviates obesity‐induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues
  publication-title: Cell Reports
– volume: 477
  start-page: 1061
  year: 2020
  end-page: 1081
  article-title: Biochemical adaptations in white adipose tissue following aerobic exercise: From mitochondrial biogenesis to browning
  publication-title: The Biochemical Journal
– volume: 3
  year: 2008
  article-title: Direct inhibition of GSK3β by the phosphorylated cytoplasmic domain of LRP6 in Wnt/β‐catenin signaling
  publication-title: PLoS One
– volume: 290
  start-page: 16744
  year: 2015
  end-page: 16758
  article-title: The Wnt inhibitor sclerostin is up‐regulated by mechanical unloading in osteocytes in vitro
  publication-title: Journal of Biological Chemistry
– volume: 38
  start-page: 1509
  year: 2015
  end-page: 1517
  article-title: Sclerostin and insulin resistance in prediabetes: Evidence of a cross talk between bone and glucose metabolism
  publication-title: Diabetes Care
– volume: 64
  start-page: 3135
  year: 2015
  end-page: 3145
  article-title: Impaired mitochondrial biogenesis in adipose tissue in acquired obesity
  publication-title: Diabetes
– volume: 26
  start-page: 19
  year: 2011
  end-page: 26
  article-title: Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
  publication-title: Journal of Bone and Mineral Research
– volume: 105
  start-page: e4023
  year: 2020
  end-page: e4037
  article-title: Response of mitochondrial respiration in adipose tissue and muscle to 8 weeks of endurance exercise in obese subjects
  publication-title: The Journal of Clinical Endocrinology & Metabolism
– volume: 25
  start-page: e59
  year: 2015
  end-page: e69
  article-title: The effect of high‐intensity training on mitochondrial fat oxidation in skeletal muscle and subcutaneous adipose tissue
  publication-title: Scandinavian Journal of Medicine and Science in Sports
– volume: 29
  start-page: 1699
  year: 2019
  end-page: 1706
  article-title: Physical training, UCP1 expression, mitochondrial density, and coupling in adipose tissue from women with obesity
  publication-title: Scandinavian Journal of Medicine and Science in Sports
– volume: 14
  start-page: 324
  year: 2011
  end-page: 338
  article-title: White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic‐adipocyte axis
  publication-title: Cell Metabolism
– volume: 1985
  start-page: 1154
  issue: 98
  year: 2005
  end-page: 1162
  article-title: The anti‐inflammatory effect of exercise
  publication-title: Journal of Applied Physiology
– volume: 18
  start-page: 749
  year: 2013
  end-page: 758
  article-title: Osteocytes regulate primary lymphoid organs and fat metabolism
  publication-title: Cell Metabolism
– volume: 97
  start-page: 3691
  year: 2012
  end-page: 3699
  article-title: Physical activity in relation to serum sclerostin, insulin‐like growth factor‐1, and bone turnover markers in healthy premenopausal women: A cross‐sectional and a longitudinal study
  publication-title: Journal of Clinical Endocrinology and Metabolism
– year: 2019
  article-title: Higher plasma sclerostin and lower Wnt signaling gene expression in white adipose tissue of prediabetic south Asian men compared with white Caucasian men
  publication-title: Diabetes & Metabolism Journal
– volume: 297
  start-page: E495
  year: 2009
  end-page: E504
  article-title: Effects of exercise training on subcutaneous and visceral adipose tissue in normal‐ and high‐fat diet‐fed rats
  publication-title: American Journal of Physiology‐Endocrinology and Metabolism
– volume: 30
  start-page: 2020
  year: 2020
  end-page: 2036
  article-title: The impact of high‐intensity interval training on inflammatory markers in metabolic disorders: A meta‐analysis
  publication-title: Scandinavian Journal of Medicine & Science in Sports
– volume: 13
  start-page: 822
  year: 1972
  end-page: 824
  article-title: Comparison of two methods for determining human adipose cell size
  publication-title: Journal of Lipid Research
– volume: 56
  start-page: 295
  year: 2007
  end-page: 303
  article-title: Wnt10b inhibits obesity in ob/ob and agouti mice
  publication-title: Diabetes
– volume: 211
  start-page: 188
  year: 2014
  end-page: 200
  article-title: Extensive changes in the transcriptional profile of human adipose tissue including genes involved in oxidative phosphorylation after a 6‐month exercise intervention
  publication-title: Acta Physiologica
– volume: 5
  start-page: 153
  issue: 2
  year: 2016
  end-page: 162
  article-title: Exercise regulation of adipose tissue
  publication-title: Adipocyte
– volume: 7
  start-page: 180
  year: 2018
  end-page: 182
  article-title: Free lipid and computerized determination of adipocyte size
  publication-title: Adipocyte
– volume: 24
  start-page: 2467
  year: 2016
  end-page: 2470
  article-title: Active individuals have high mitochondrial content and oxidative markers in their abdominal subcutaneous adipose tissue
  publication-title: Obesity
– volume: 145
  issue: 11
  year: 2018
  article-title: Wnt signaling in development and tissue homeostasis
  publication-title: Development
– volume: 81
  start-page: 92
  year: 2019
  end-page: 104
  article-title: Exercise training, circulating cytokine levels and immune function in cancer survivors: A meta‐analysis
  publication-title: Brain, Behavior, and Immunity
– volume: 122
  start-page: 2405
  year: 2012
  end-page: 2416
  article-title: Secreted frizzled‐related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition
  publication-title: The Journal of Clinical Investigation
– volume: 114
  start-page: E11238
  year: 2017b
  end-page: E11247
  article-title: Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
  publication-title: Proceedings of the National Academy of Sciences
– volume: 9
  year: 2014
  article-title: Role of IL‐6 in exercise training‐ and cold‐induced UCP1 expression in subcutaneous white adipose tissue
  publication-title: PLoS One
– volume: 200
  start-page: 325
  year: 2010
  end-page: 338
  article-title: Effects of exercise training on adipogenesis of stromal‐vascular fraction cells in rat epididymal white adipose tissue
  publication-title: Acta Psychologica
– volume: 229
  start-page: 640
  year: 2014
  end-page: 650
  article-title: TNF‐α upregulates sclerostin expression in obese mice fed a high‐fat diet
  publication-title: Journal of Cellular Physiology
– volume: 8
  issue: 8
  year: 2013
  article-title: Dissociation of increases in PGC‐ 1α and its regulators from exercise intensity and muscle activation following acute exercise
  publication-title: PLoS One
– volume: 25
  start-page: 122
  year: 2017
  end-page: 131
  article-title: Comparative analysis of three human adipocyte size measurement methods and their relevance for cardiometabolic risk
  publication-title: Obesity
– volume: 64
  start-page: 2002
  year: 2015
  end-page: 2014
  article-title: A novel role for subcutaneous adipose tissue in exercise‐induced improvements in glucose homeostasis
  publication-title: Diabetes
– volume: 172
  start-page: 1199
  year: 2005
  end-page: 1209
  article-title: Behavioural treatments for chronic systemic inflammation: Effects of dietary weight loss and exercise training
  publication-title: Canadian Medical Association Journal
– volume: 13
  start-page: 785
  year: 2020
  end-page: 810
  article-title: The Exercise training modulatory effects on the obesity‐induced immunometabolic dysfunctions
  publication-title: Diabetes, Metabolic Syndrome and Obesity
– volume: 1985
  start-page: 1585
  issue: 125
  year: 2018
  end-page: 1593
  article-title: Exercise training‐induced effects on the abdominal subcutaneous adipose tissue phenotype in humans with obesity
  publication-title: Journal of Applied Physiology
– volume: 587
  start-page: 1607
  year: 2009
  end-page: 1617
  article-title: Exercise and adrenaline increase PGC‐1α mRNA expression in rat adipose tissue
  publication-title: The Journal of Physiology
– volume: 481
  start-page: 463
  year: 2012
  end-page: 468
  article-title: A PGC1‐α‐dependent myokine that drives brown‐fat‐like development of white fat and thermogenesis
  publication-title: Nature
– volume: 32
  start-page: 1496
  year: 2017
  end-page: 1504
  article-title: BPS804 anti‐sclerostin antibody in adults with moderate osteogenesis imperfecta: Results of a randomized phase 2a trial
  publication-title: Journal of Bone and Mineral Research
– volume: 24
  start-page: 1571
  year: 2005
  end-page: 1583
  article-title: Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
  publication-title: The EMBO Journal
– volume: 390
  start-page: 1585
  year: 2017
  end-page: 1594
  article-title: Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: A randomised, open‐label, phase 3 trial
  publication-title: The Lancet
– volume: 97
  start-page: E1473
  year: 2012
  end-page: E1477
  article-title: Association of circulating sclerostin levels with fat mass and metabolic disease–related markers in Japanese postmenopausal women
  publication-title: Journal of Clinical Endocrinology and Metabolism
– volume: 24
  start-page: 1651
  year: 2009
  end-page: 1661
  article-title: Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta‐catenin signaling
  publication-title: Journal of Bone and Mineral Research
– volume: 9
  year: 2018
  article-title: Exercise induces white adipose tissue browning across the weight spectrum in humans
  publication-title: Frontiers in Physiology
– volume: 38
  start-page: 1044
  year: 2014
  end-page: 1052
  article-title: The small molecule indirubin‐3'‐oxime activates Wnt/β‐catenin signaling and inhibits adipocyte differentiation and obesity
  publication-title: International Journal of Obesity
– volume: 42
  start-page: 721
  year: 2018
  end-page: 727
  article-title: No evidence of white adipocyte browning after endurance exercise training in obese men
  publication-title: International Journal of Obesity
– volume: 9
  start-page: 38
  issue: 3
  year: 2021
  article-title: Proteomes are of proteoforms: Embracing the complexity
  publication-title: Proteomes
– volume: 47
  start-page: 2034
  year: 2015
  end-page: 2042
  article-title: Adipose tissue insulin action and IL‐6 signaling after exercise in obese mice
  publication-title: Medicine and Science in Sports and Exercise
– volume: 35
  year: 2021
  article-title: Bone‐derived sclerostin and Wnt/β‐catenin signaling regulate PDGFRα+ adipoprogenitor cell differentiation
  publication-title: The FASEB Journal
– volume: 15
  start-page: 492
  year: 2012
  end-page: 504
  article-title: Wnt signaling activation in adipose progenitors promotes insulin‐independent muscle glucose uptake
  publication-title: Cell Metabolism
– ident: e_1_2_9_3_1
  doi: 10.1210/jc.2011‐3361
– ident: e_1_2_9_71_1
  doi: 10.1152/japplphysiol.00496.2018
– ident: e_1_2_9_7_1
  doi: 10.1038/nature10777
– ident: e_1_2_9_65_1
  doi: 10.2147/DMSO.S234992
– ident: e_1_2_9_22_1
  doi: 10.1210/clinem/dgaa571
– ident: e_1_2_9_41_1
  doi: 10.1249/MSS.0000000000000660
– ident: e_1_2_9_61_1
  doi: 10.1016/j.cmet.2013.09.014
– ident: e_1_2_9_81_1
  doi: 10.2337/db06-1339
– ident: e_1_2_9_18_1
  doi: 10.1123/ijsnem.22.4.276
– ident: e_1_2_9_25_1
  doi: 10.1111/sms.13754
– ident: e_1_2_9_70_1
  doi: 10.1242/dev.146589
– ident: e_1_2_9_15_1
  doi: 10.1016/j.celrep.2019.02.014
– ident: e_1_2_9_33_1
  doi: 10.1002/oby.21697
– ident: e_1_2_9_12_1
  doi: 10.2337/dc14‐2989
– ident: e_1_2_9_2_1
  doi: 10.1210/jc.2011‐2152
– ident: e_1_2_9_28_1
  doi: 10.1074/jbc.RA118.006769
– ident: e_1_2_9_55_1
  doi: 10.1002/oby.21669
– ident: e_1_2_9_11_1
  doi: 10.1038/ijo.2013.209
– ident: e_1_2_9_10_1
  doi: 10.3390/proteomes9030038
– ident: e_1_2_9_5_1
  doi: 10.1002/jcp.24487
– ident: e_1_2_9_73_1
  doi: 10.1080/21623945.2018.1489335
– ident: e_1_2_9_35_1
  doi: 10.1111/sms.12252
– ident: e_1_2_9_16_1
  doi: 10.1002/jbmr.3143
– ident: e_1_2_9_34_1
  doi: 10.1016/S0140‐6736(17)31613‐6
– ident: e_1_2_9_53_1
  doi: 10.1152/japplphysiol.00164.2004
– ident: e_1_2_9_57_1
  doi: 10.1111/apha.12247
– ident: e_1_2_9_44_1
  doi: 10.1038/sj.emboj.7600633
– ident: e_1_2_9_59_1
  doi: 10.18632/oncotarget.24707
– ident: e_1_2_9_13_1
  doi: 10.14814/phy2.13857
– ident: e_1_2_9_77_1
  doi: 10.1210/jc.2012‐1218
– ident: e_1_2_9_20_1
  doi: 10.1016/j.bbrc.2014.03.079
– ident: e_1_2_9_51_1
  doi: 10.1002/jbmr.173
– ident: e_1_2_9_38_1
  doi: 10.1016/j.mce.2008.05.005
– ident: e_1_2_9_75_1
  doi: 10.2337/db13‐1234
– ident: e_1_2_9_60_1
  doi: 10.1016/j.exger.2018.07.021
– ident: e_1_2_9_72_1
  doi: 10.1113/jphysiol.2008.165464
– ident: e_1_2_9_74_1
  doi: 10.1016/j.cyto.2013.09.018
– ident: e_1_2_9_69_1
  doi: 10.1159/000497113
– ident: e_1_2_9_62_1
  doi: 10.1007/s11914‐015‐0269‐9
– ident: e_1_2_9_63_1
  doi: 10.1016/S0022‐2275(20)39356‐1
– ident: e_1_2_9_31_1
  doi: 10.1073/pnas.1707876115
– ident: e_1_2_9_43_1
  doi: 10.1042/BCJ20190466
– ident: e_1_2_9_52_1
  doi: 10.1007/s10741‐018‐9677‐0
– ident: e_1_2_9_49_1
  doi: 10.3389/fphys.2018.01781
– ident: e_1_2_9_58_1
  doi: 10.1111/j.1748‐1716.2010.02159.x
– ident: e_1_2_9_78_1
  doi: 10.1016/j.cmet.2018.12.007
– ident: e_1_2_9_26_1
  doi: 10.1016/j.bbi.2019.08.187
– ident: e_1_2_9_29_1
  doi: 10.1096/fj.202100691R
– ident: e_1_2_9_32_1
  doi: 10.1371/journal.pone.0084910
– ident: e_1_2_9_67_1
  doi: 10.1080/21623945.2016.1191307
– ident: e_1_2_9_40_1
  doi: 10.1074/jbc.M402937200
– ident: e_1_2_9_8_1
  doi: 10.1111/sms.13514
– ident: e_1_2_9_21_1
  doi: 10.1016/j.bone.2016.10.011
– ident: e_1_2_9_48_1
  doi: 10.1111/febs.12619
– ident: e_1_2_9_47_1
  doi: 10.1503/cmaj.1040769
– ident: e_1_2_9_64_1
  doi: 10.1016/j.molmet.2016.12.001
– ident: e_1_2_9_30_1
  doi: 10.1073/pnas.1707876115
– ident: e_1_2_9_42_1
  doi: 10.1038/s41598‐018‐21795‐y
– ident: e_1_2_9_36_1
  doi: 10.1152/japplphysiol.01080.2011
– ident: e_1_2_9_54_1
  doi: 10.1371/journal.pone.0004046
– ident: e_1_2_9_9_1
  doi: 10.1016/j.cmet.2011.06.020
– ident: e_1_2_9_24_1
  doi: 10.4093/dmj.2019.0031
– ident: e_1_2_9_4_1
  doi: 10.1152/ajpendo.00248.2007
– ident: e_1_2_9_19_1
  doi: 10.2337/db14‐1937
– ident: e_1_2_9_46_1
  doi: 10.1016/j.msard.2018.06.008
– ident: e_1_2_9_17_1
  doi: 10.1152/ajpendo.90424.2008
– ident: e_1_2_9_56_1
  doi: 10.1139/apnm‐2017‐0864
– ident: e_1_2_9_14_1
  doi: 10.1371/journal.pone.0071623
– ident: e_1_2_9_6_1
  doi: 10.1002/jbmr.320
– ident: e_1_2_9_66_1
  doi: 10.1074/jbc.M114.628313
– volume: 69
  start-page: 142
  year: 2018
  ident: e_1_2_9_23_1
  article-title: Effects of physical activity on sclerostin concentrations
  publication-title: Endokrynologia Polska
  contributor:
    fullname: Janik M.
– ident: e_1_2_9_39_1
  doi: 10.1359/jbmr.090411
– ident: e_1_2_9_76_1
  doi: 10.1038/ijo.2017.295
– ident: e_1_2_9_80_1
  doi: 10.1371/journal.pone.0102406
– ident: e_1_2_9_82_1
  doi: 10.1016/j.cmet.2012.03.010
– ident: e_1_2_9_37_1
  doi: 10.1016/j.isci.2018.12.033
– ident: e_1_2_9_27_1
  doi: 10.1038/s41467‐020‐19155‐4
– ident: e_1_2_9_83_1
  doi: 10.2337/db13‐1106
– ident: e_1_2_9_50_1
  doi: 10.1002/jcph.239
– ident: e_1_2_9_68_1
  doi: 10.2337/db14‐0704
– ident: e_1_2_9_45_1
  doi: 10.1172/JCI63604
– ident: e_1_2_9_79_1
  doi: 10.1016/j.bone.2018.07.021
SSID ssj0001033904
Score 2.3249524
Snippet Sclerostin is a Wnt/β‐catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest...
Sclerostin is a Wnt/β-catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents suggest...
Abstract Sclerostin is a Wnt/β‐catenin antagonist, mainly secreted by osteocytes, and most known for its role in reducing bone formation. Studies in rodents...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e15232
SubjectTerms Adipocytes
Adipose tissue
beta Catenin - metabolism
Biopsy
Biosynthesis
Body fat
Bone growth
Bone mass
bone–adipose tissue crosstalk
Carbohydrates
Catenin
Exercise
Fitness training programs
Gene expression
High-Intensity Interval Training
Humans
Insulin resistance
Interleukin 6
Interval training
Laboratories
Male
Metabolism
Obesity
Obesity - therapy
Original
Osteocytes
Osteogenesis
Phosphorylation
Physical fitness
Physical training
Proteins
sclerostin
SOST protein
sprint interval training
Subcutaneous Fat - metabolism
Wnt protein
Wnt signaling
Wnt Signaling Pathway
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagJy4IKD-Bggap4oKiJraz6xwLtNoTQgIEnCw7nqgRqlM1u6p64xF67evxJMw42VVXILhwi-xYmnjG42-c8TdC7BcSVWU85lVbqVyboHJPMDY32lN0UAbvEnfn4uP8_Vfz7ohpcjalvjgnbKQHHifuAHWhpJ_TGDUjMK8dhQitUap1ZYFrsu3C3Aim0ulKoSiY19OFPG1KfUBSS672o-TWFpSY-v8EL3_PkryJXtP2c3xP3J1wIxyO8t4XtzA-ELuHkWLm00t4BSmTMx2R74pr8gbNilAfUlgPLnRn_YCwTFMMAw3nmx5dhG6Ac2ZuxQAuBvgSl8DpHI5vqHMnxpOUHwAtGUt_wa3654-rC8TvA_QtpH-6S-hS2iQJty43QS1wyV4ETjECn_RCP9YfeCg-Hx99ervIpxIMeaPJTeYBKeJBpmlzjdStrgyptgrS65qcg9cFNqVrC-dRz-swqyUW2gXfShqngm_UI7ET-4hPBDR160ktWPGOiMbXpnGS0GKQ5czLEDKxv9aKPRuZNixHKKw8y8qzSXmZeMMa27zC9NipgYzGTkZj_2U0mdhb69tOa3awDA0lfWFVZ-LlpptWG_9CGVXG7xBEYoKcTDwezWMjiSJ3xoAzE_Mtw9kSdbsndieJ0dswy70isV4nE_vb99sPi28yPT39HzPxTNyRfKEjZdXtiZ3l-Qqfi9tDWL1IK-oXvhknxQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Subcutaneous adipose tissue sclerostin is reduced and Wnt signaling is enhanced following 4‐weeks of sprint interval training in young men with obesity
URI https://onlinelibrary.wiley.com/doi/abs/10.14814%2Fphy2.15232
https://www.ncbi.nlm.nih.gov/pubmed/35312183
https://www.proquest.com/docview/2644245859
https://www.proquest.com/docview/2641516840
https://pubmed.ncbi.nlm.nih.gov/PMC8935536
https://doaj.org/article/e4032b7ba2364954a828f833fa10e006
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtNAEF6RnrggoPwYSjVIFRfkxtldJ_axlFa5gCoBAk7WrndMLcg6ihNVvfEIXHk9noSZtR01AnHgFu3aytjz7ezMeuYbIY4SiSrNLMZplapYZ07FltzYONOWooOJsyZwd87fzd5-yl6fMU1OOtTChKT90tbH_tvi2NeXIbdyuSjHQ57Y-OLNacak4Go6HokR-YY3QvRwsJIoiuN1X4uns4kek8CSG_0o7l2jCHXsF-xsRIGv_29O5p-5kjd92LAJnd8Vd3rvEU46Ke-JW-jvi_0TT5Hz4hpeQMjnDAfl--In2YRyQ74fUnAPxtXLpkVYhxcNLd3O9R61h7qFFfO3ogPjHXz0a-CkDsN16jyJ_jJkCUBFkGmueFT_-v7jCvFrC00F4cvuGuqQPEnCDU0naASu2ZbAAj3weS80XReCB-LD-dn703ncN2KIS03GMnZIcQ8yWZsppa50mpGCUyetzslEWJ1gOTFVYizqWe6mucREG2crSfcpZ0v1UOz5xuNjAWVeWdIQprwvYmbzrDSSfEYnJ1MrnYvE0aCVYtnxbRQcp7AeC9ZjEfQYiVesse0lTJIdBprVl6KHSoE6UdLOCG5qSnGgNhRdVplSlZkkSNYmEgeDvot-5bYFO4iSnjDNI_F8O01rjj-kdCrja8hRYpqcSDzq4LGVZIBXJGY7wNkRdXeGYB54vXtYR-JlgNi_nr-4mH-W4deT__6fp-K25FqOkFB3IPbWqw0-E6PWbQ7DycRhWFe_ARYNKl4
link.rule.ids 230,315,729,782,786,866,887,2108,27935,27936,53803,53805
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZoOcCFv0JJKWCkigtKN7Gd3eRYSqtFtFUlioBTZMcTGtF1VptdVb3xCFx5PZ6EGSdZdQXi0FtkJ4qt-TyesWe-YWwnEiCT1ECYlIkMVWplaNCMDVNl0DuIrdGeu3P8cXTyJX13QDQ5SZ8L44P2C1PtuovJrqvOfWzldFIM-jixwenxfkqk4HI4WGO3cb1G8pqT7o9WIomevOqy8VQaqwEOWVCpH0nVayTijiyDla3IM_b_y8z8O1ryuhXrt6HD-zecwAN2r7M7-V7b_ZDdAveIbew59LknV_w195Gg_oh9g_1CbVIs0GqEetFwbatp3QCfexHxBj-nTJHK8arhM2J-Bcu1s_yzm3MKB9GU4U6d4M59fAEvEWz1JbWq3z9-XgJ8b3hdcn8nPOeVD7vEwfXlKrCFX5EW4hNwnE6Ked3WL3jMPh0enO2Pw66EQ1goVLOhBfSYgGjedCFUqZIUoZFYYVSGysWoCIpYl5E2oEaZHWYCIqWtKQV-J60p5BO27moHTxkvstKgZCGhHRVSk6WFFmhtWhEPjbA2YDu9NPNpy9SRk4dD8s9J_rmXf8DekqSXrxC9tm-oZ9_yTkY5qEgKM0KgyiF6kEqjX1qmUpY6jgD1VMC2e5zk3ZpvcjItBc4wyQL2atmNq5WuYFqR0TtoYhHBTsA2W1gtR9LDMmCjFcCtDHW1B_HlGcE7PAXsjYfm_-afn46_Cv-0deP_vGR3xmfHR_nR-5MPz9hdQRkhPixvm63PZwt4ztYau3jhV-UfByY--w
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB7RIiEu_BVKoICRKi4oTWI7u8mxtF0tAqqVAAGnyI4dGsE6q82uqt54BK68Hk_CjJNddQXiALfIP4qt-TyescffAOzH3Io00zZMq1SEMjMi1GjGhpnU6B0kRivP3Tl-Ozz9mB2fEE3OOtWXD9ovdX3gvk4PXH3mYytn0zJaxYlFkzdHGZGCi0E0M1W0BVdxzcbpJUfdH6_EAr152b_Ik1kiIxw2p3Q_gjLYCMQeWQcb25Fn7f-Tqfl7xORlS9ZvRaOb_zGJW3Cjtz_ZYdfkNlyx7g7sHDr0vacX7BnzEaH-qH0HfqBWKZdoPdpm2TJl6lnTWrbwomItdqcXI7VjdcvmxABrDVPOsA9uwSgsRNFLd6q07szHGbAKQdecU6n8-e37ubVfWtZUzN8NL1jtwy9xcKu0FVjCLkgbsal1jE6MWdPlMbgL70cn747GYZ_KISwlqtvQWPScLNG9qZLLSqYZQiQ1XMsclYyWsS0TVcVKWznMzSDnNpbK6IpjP2F0Ke7BtmucvQ-szCuN0rUp7aw203lWKo5Wp-HJQHNjAthfSbSYdYwdBXk6hIGCMFB4DATwgqS9bkI0276gmX8uejkVVsaC6yECVgzQk5QK_dMqE6JSSWxRXwWwt8JK0a_9tiATk-MM0zyAp-tqXLV0FdOJjNqgqUVEOwHsdtBaj2QFzQCGG6DbGOpmDWLMM4P3mArguYfn3-ZfTMafuP968M__eQLXJsej4vXL01cP4TqnhyE-Om8PthfzpX0EW61ZPvYL8xfdM0F7
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subcutaneous+adipose+tissue+sclerostin+is+reduced+and+Wnt+signaling+is+enhanced+following+4%E2%80%90weeks+of+sprint+interval+training+in+young+men+with+obesity&rft.jtitle=Physiological+reports&rft.au=Kurgan%2C+Nigel&rft.au=Islam%2C+Hashim&rft.au=Matusiak%2C+Jennifer+B.+L.&rft.au=Baranowski%2C+Bradley+J.&rft.date=2022-03-01&rft.eissn=2051-817X&rft.volume=10&rft.issue=6&rft.epage=n%2Fa&rft_id=info:doi/10.14814%2Fphy2.15232&rft.externalDBID=10.14814%252Fphy2.15232&rft.externalDocID=PHY215232
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2051-817X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2051-817X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2051-817X&client=summon